Quiet Therapeutics, founded in 2010 is developing novel siRNA delivery solutions. Its proprietary GAGomer nanoparticles are unique in their ability to deliver nucleic acids based on the recognition of a validated marker expressed by cancer cells.
Company (Alive / Active)
7 Pinchas Sapi
Ness Ziona, 74140
|Investor||Investor Type||Location||Participating Rounds|